Publications

Detailed Information

WNT signaling in glioblastoma and therapeutic opportunities

Cited 178 time in Web of Science Cited 185 time in Scopus
Authors

Lee, Yeri; Lee, Jin-Ku; Ahn, Sun Hee; Lee, Jeongwu; Nam, Do-Hyun

Issue Date
2016-02
Publisher
Nature Publishing Group
Citation
Laboratory Investigation, Vol.96 No.2, pp.137-150
Abstract
WNTs and their downstream effectors regulate proliferation, death, and migration and cell fate decision. Deregulation of WNT signaling is associated with various cancers including GBM, which is the most malignant primary brain cancer. In this review, we will summarize the experimental evidence supporting oncogenic roles of WNT signaling in GBM and discuss current progress in the targeting of WNT signaling as an anti-cancer approach. In particular, we will focus on (1) genetic and epigenetic alterations that lead to aberrant WNT pathway activation in GBM, (2) WNT-mediated control of GBM stem cell maintenance and invasion, and (3) cross-talk between WNT and other signaling pathways in GBM. We will then review the discovery of agents that can inhibit WNT signaling in preclinical models and the current status of human clinical trials.
ISSN
0023-6837
URI
https://hdl.handle.net/10371/191551
DOI
https://doi.org/10.1038/labinvest.2015.140
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area 3D drug screening, Cancer Organoid, Precision Oncologuy

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share